The top after-market NASDAQ stock market gainers are: Mitel Networks, Zumiez, BioMimetic Therapeutics, Zhongpin, PMC-Sierra, and Clearwire. The top after-market NASDAQ stock market losers are: Viacom, Angie's List, Ebix, AVEO Pharmaceuticals, Avago Technologies, and Equinix.

Gainers

Mitel Networks Corp. (MITL) stock jumped 18.61 percent to $3.25 in after-market trading. Loss for the second quarter was $1.2 million or $0.02 per share, compared to a profit of $80.9 million or $1.45 per share last year. Adjusted earnings were $13.3 million or $0.24 per share, up from $9.1 million or $0.16 per share last year. Revenue rose to $168.8 million from $161.1 million. Analysts had expected profit of $0.17 per share on revenue of $166.02 million. Looking ahead into the third quarter, the company expects revenue of $164 million to $170 million, while Wall Street predicts $167.89 million.

Zumiez Inc. (ZUMZ) stock climbed 11.25 percent to $26 in after-market trading. Profit for the third quarter was $14.1 million or $0.45 per share, up from $12.3 million or $0.40 per share last year. Sales grew 13.3 percent to $154 million. Analysts had expected profit of $0.42 per share on revenue of $153.06 million. Comparable store sales increased 6 percent. Looking ahead into the fourth quarter, the company expects earnings of about $0.52 to $0.54 per share and revenue of $174 million to $177 million, while Street predicts profit of $0.52 per share on revenue of $173.61 million. The company anticipates comparable store sales to increase in the mid-single-digit range.

BioMimetic Therapeutics Inc. (BMTI) stock grew 7.38 percent to $3.20 in after-market trading. The shares recovered after it closed Thursday's regular trading down 5.10 percent at $2.98.

Zhongpin Inc. (HOGS) stock gained 3.59 percent to $9.80 in after-market trading. The shares closed Thursday's regular trading up 0.42 percent at $9.46.

PMC-Sierra Inc. (PMCS) stock increased 3.49 percent to $5.63 in after-market trading. The shares recovered after it closed down 2.68 percent at $5.44 on Thursday.

Clearwire Corp. (CLWR) stock rose 3.45 percent to $2.10 in after-market trading. Sprint Nextel Corp. (S) and Clearwire announced agreements potentially worth up to $1.6 billion over the next four years in payments for WiMAX services, possible pre-payments for LTE services and potential equity investments. Clearwire also said it has made interest payments totaling $237 million on its first-priority, second-priority and exchangeable notes which were due Dec. 1. Clearwire said the agreements modify prior wholesale pricing agreements and provide Sprint with unlimited access to Clearwire's WiMAX network to meet its growing 4G data demands. Under the terms of the agreements, Sprint will pay Clearwire a total of $926 million, about two-thirds of which will be paid in 2012, for unlimited 4G WiMAX retail services during 2012 and 2013. The agreements also establish long-term usage-based pricing for WiMAX services in 2014 and beyond. Sprint will have access to Clearwire's WiMAX network through at least 2015. Sprint plans to continue selling WiMAX devices with two-year contracts through at least 2012 and support those devices through the life of the contract.

Clearwire said the agreements also lay the foundation for the deployment of Clearwire's planned LTE Advanced-ready overlay network and outline the terms for Sprint to gain access to the additional LTE capacity. Under the terms, Sprint will pay Clearwire up to $350 million in a series of prepayments over a period of up to two years for LTE capacity if Clearwire achieves certain build-out targets and network specifications by June 2013. In addition, Clearwire and Sprint will work collaboratively to support the ecosystem for TDD-LTE in Band Class 41 for devices, chipsets and standards. Sprint expects to launch devices including laptop cards and phones that will utilize Clearwire's TDD-LTE network in 2013. Sprint has committed to providing additional equity funding to Clearwire in the event of an equity offering. If Clearwire raises new equity between $400 and $700 million, Sprint will participate in the offering on a pro rata basis up to $347 million.

Losers

Viacom, Inc. (VIAB) stock declined 4.31 percent to $43.12 in after-market trading.

Angie's List Inc. (ANGI) stock decreased 3.97 percent to $12.0515 in after-market trading. The shares closed Thursday's regular trading up 8.61 percent at $12.55.

Ebix Inc. (EBIX) stock declined 3.43 percent to $20.29 in after-market trading. The shares closed down 2.28 percent at $21.01 on Thursday.

AVEO Pharmaceuticals Inc. (AVEO) stock decreased 3.03 percent to $16.31 in after-market trading. The company and Boehringer Ingelheim announced that they have entered into an agreement for large-scale process development and clinical manufacturing of ficlatuzumab, AVEO’s novel HGF inhibitory antibody that is currently in Phase 2 clinical development in patients with non-small cell lung cancer (NSCLC). Boehringer Ingelheim will produce ficlatuzumab for clinical trials at its biopharmaceutical site in Fremont, USA. AVEO retains all rights to the development and commercialization of ficlatuzumab. Financial terms of the agreement were not disclosed.

Avago Technologies Ltd. (AVGO) stock declined 2.71 percent to $29.10 in after-market trading. Profit for the fourth quarter was $154 million or $0.61 per share, down from $164 million or $0.66 per share last year. Adjusted profit was $186 million or $0.73 per share, lower than last year's $190 million or $0.76 per share. Revenue rose 9 percent to $623 million. Analysts had expected profit of $0.67 per share on revenue of $620.8 million. Looking ahead into the first quarter, the company expects revenue to decline sequentially 10 percent to 14 percent. The company projects capital expenditure of $40 million to $45 million, depreciation of $19 million and amortization of $19 million. For the full year 2012, the company anticipates capital expenditure of about $200 million.

Equinix Inc. (EQIX) stock decreased 2.44 percent to $99.50 in after-market trading. The shares closed Thursday's regular trading up 1.97 percent at $101.99.